# Xencor Inc: insider transactions

SEC CIK 1326732. Roles and transactions as reported on Form 4. Latest Form 4 filed 2021-09-08.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Inmune Bio, Inc.](/companies/inmb.md) | 10% owner | 5 | 2021-06-10 | 2021-09-03 |

## Transactions: 5

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-09-03 | [Inmune Bio, Inc.](/companies/inmb.md) | Option exercise (M), derivative | 108,000 | $0.00 | $0 | [Form 4](/filings/0001415889-21-004281.md) |
| 2021-09-03 | [Inmune Bio, Inc.](/companies/inmb.md) | Option exercise (M) | 108,000 | $7.80 | $842.4k | [Form 4](/filings/0001415889-21-004281.md) |
| 2021-06-10 | [Inmune Bio, Inc.](/companies/inmb.md) | Other (J) | 192,532 | $17.14 | $3.3m | [Form 4](/filings/0001415889-21-002991.md) |
| 2021-06-10 | [Inmune Bio, Inc.](/companies/inmb.md) | Other (J) | 192,533 | $17.14 | $3.3m | [Form 4/A](/filings/0001415889-21-004279.md) |
| 2021-06-10 | [Inmune Bio, Inc.](/companies/inmb.md) | Other (J) | 192,533 | $17.14 | $3.3m | [Form 4/A](/filings/0001415889-21-004280.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 11:47 ET. No prices; not investment advice.